Aptar Digital Health announced that the FDA has granted 510(k) clearance for HeroTracker Sense as a Class II medical device.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATR:
- AptarGroup price target lowered to $167 from $175 at BofA
- Nasus Pharma announces expanded agreement to support NS002
- AptarGroup’s Strategic Shift to Pharma Drives Buy Rating Amid Profitability Gains
- AptarGroup price target lowered to $152 from $153 at Wells Fargo
- AptarGroup: Balancing Long-Term Potential with Short-Term Challenges – Hold Rating